The SENSE engine from Sensyne Health will leverage algorithms, known as SYNEs, in order to deliver real-time decision support across multiple medical conditions.
The system will produce an algorithm for providing more personalised care to Covid-19 patients at Chelsea & Westminister Hospital, called SYNE-COV, following Sensyne’s first agreement with Chelsea & Westminster Hospital NHS Foundation Trust.
SYNE-COV will operate by analysing real-world evidence data collected in Chelsea & Westminster A&E. This data will be integrated into a dashboard which clinicians can use to augment decisions for three outcomes:
- Risk of ICU admission
- Need for mechanical ventilation
- In-hospital mortality
Driving healthcare transformation one simple step at a time
Lord Paul Drayson, CEO of Sensyne Health, said: “The SENSE system is a major step forward in unifying different elements of our clinical AI technology together with Microsoft’s health cloud technology to deliver multiple clinical algorithms at scale.
“We are delighted to announce the first SYNE algorithm from this approach, developed in collaboration with Chelsea & Westminster NHS Foundation Trust, designed and built to help the NHS cope with a potential second wave of COVID-19.”
Robert Hodgkiss, deputy chief executive of Chelsea & Westminster Hospital NHS Foundation Trust, commented: “Chelsea and Westminster has a long tradition of innovation. It supports our key purpose to provide high quality care for patients and making the best use of resources.
“We took major steps forward in our agile working during the Covid-19 pandemic and we are committed to supporting our clinicians to make crucial treatment decisions on the front line. We are proud of the development of this product and its potential for patient benefit.”
Algorithms for other conditions are currently being developed and to be announced, along with details of further roll-out across the UK. In addition, Sensyne intends to launch its SENSE system and associated SYNE algorithms in the United States towards the end of the current financial year.
Global deployment of SENSE will be made possible by Sensyne’s partnership with Microsoft.